NASDAQ:SNTA   SYNTA PHARMACEUTICALS CORP
8 0 0
The market isn't seeing SNTA's true potential. This stock is deeply undervalued at the moment. A true price range it should trade at would be $1.10 - $ 1.75 in the medium term even without any effects of expected positive news. SNTA's merger with Madrigal Pharma             is also being discounted, while in actual fact it's a great combination, the management details would stand testament to that.
United States
United Kingdom
India
Deutschland
France
España
Italia
Polska
Türkiye
Россия
Brasil
Indonesia
Malaysia
ประเทศไทย
Việt Nam
日本
한국
简体
繁體
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out